ProMIS Neurosciences PMN
NASDAQ PMN
$14.70 -0.21 (-1.42%)
As of: Aug 21, 2026 · 12:17 PM EDT

ProMIS Neurosciences (PMN) EPS (Basic) Growth (5y) (2026)

ProMIS Neurosciences (PMN) EPS (Basic) Growth (5y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.82 Bn 131.97 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.70 Bn 78.71 Bn 3.93 Bn
3 Argenx Se 65.27 Bn 60.09 Bn 1.37 Bn
4 Moderna 59.18 Bn 54.04 Bn 52.00 Mn
5 BeOne Medicines 42.11 Bn 37.01 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn
7 BioNTech SE 28.14 Bn 9.75 Bn 668.28 Mn
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn
9 Royalty Pharma 27.26 Bn 26.42 Bn -
10 ProMIS Neurosciences 134.39 Mn 80.93 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 26.73%